BOLT
Price
$0.35
Change
-$0.02 (-5.41%)
Updated
Apr 29, 03:53 PM (EDT)
Capitalization
14.19M
9 days until earnings call
CYTK
Price
$41.26
Change
+$0.04 (+0.10%)
Updated
Apr 29, 04:59 PM (EDT)
Capitalization
4.91B
7 days until earnings call
Ad is loading...

BOLT vs CYTK

Header iconBOLT vs CYTK Comparison
Open Charts BOLT vs CYTKBanner chart's image
Bolt Biotherapeutics
Price$0.35
Change-$0.02 (-5.41%)
Volume$25.26K
Capitalization14.19M
Cytokinetics
Price$41.26
Change+$0.04 (+0.10%)
Volume$21.83K
Capitalization4.91B
BOLT vs CYTK Comparison Chart
Loading...
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BOLT vs. CYTK commentary
Apr 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLT is a StrongBuy and CYTK is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 29, 2025
Stock price -- (BOLT: $0.37 vs. CYTK: $41.22)
Brand notoriety: BOLT and CYTK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLT: 80% vs. CYTK: 43%
Market capitalization -- BOLT: $14.19M vs. CYTK: $4.91B
BOLT [@Biotechnology] is valued at $14.19M. CYTK’s [@Biotechnology] market capitalization is $4.91B. The market cap for tickers in the [@Biotechnology] industry ranges from $272.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLT’s FA Score shows that 1 FA rating(s) are green whileCYTK’s FA Score has 1 green FA rating(s).

  • BOLT’s FA Score: 1 green, 4 red.
  • CYTK’s FA Score: 1 green, 4 red.
According to our system of comparison, CYTK is a better buy in the long-term than BOLT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLT’s TA Score shows that 5 TA indicator(s) are bullish while CYTK’s TA Score has 5 bullish TA indicator(s).

  • BOLT’s TA Score: 5 bullish, 3 bearish.
  • CYTK’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BOLT is a better buy in the short-term than CYTK.

Price Growth

BOLT (@Biotechnology) experienced а +8.56% price change this week, while CYTK (@Biotechnology) price change was +8.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was -1.11%, and the average quarterly price growth was -9.86%.

Reported Earning Dates

BOLT is expected to report earnings on Aug 06, 2025.

CYTK is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($4.91B) has a higher market cap than BOLT($14.2M). CYTK YTD gains are higher at: -12.372 vs. BOLT (-30.817). BOLT has higher annual earnings (EBITDA): -70.51M vs. CYTK (-493.48M). CYTK has more cash in the bank: 1.08B vs. BOLT (53.8M). BOLT has less debt than CYTK: BOLT (18.2M) vs CYTK (789M). CYTK has higher revenues than BOLT: CYTK (18.5M) vs BOLT (9.78M).
BOLTCYTKBOLT / CYTK
Capitalization14.2M4.91B0%
EBITDA-70.51M-493.48M14%
Gain YTD-30.817-12.372249%
P/E RatioN/AN/A-
Revenue9.78M18.5M53%
Total Cash53.8M1.08B5%
Total Debt18.2M789M2%
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
65
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BOLTCYTK
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 5 days ago
70%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 8 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NXTC0.46N/A
+1.04%
NextCure
OB3.80-0.03
-0.78%
Outbrain
PLXS125.70-1.10
-0.87%
Plexus Corp
NOK4.91-0.08
-1.60%
Nokia Corp
EOLS11.31-0.34
-2.92%
Evolus